Suchergebnisse - "Martínez-López, Joaquín"

PubPharm (482)

1

Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia : a study by the Spanish PETHEMA registry

enthalten in: Haematologica | 2024

von De la Torre, E. | Serrano, J. | Martínez-Cuadrón, D. | +29

2

Ponalfil trial for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia : Long-term results

enthalten in: HemaSphere | 2024

von Ribera, J. | Morgades, M. | Ribera, J. | +14

3

A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

enthalten in: Preprints.org | 2024

von Ríos-Tamayo, R. | Lecumberri, R. | Cibeira, M. | +16

4

Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study

enthalten in: Annals of hematology | 2024

von Pérez-Lamas, L. | de Paz Arias, R. | Díaz, R. | +10

5

Author Correction : Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

enthalten in: Scientific reports | 2024

von Sánchez, R. | Dorado, S. | Ruíz-Heredia, Y. | +44

ErratumFor: Sci Rep. 2022 Jul 29;12(1):13057. - PMID 35906470

6

Detection of Kinase Domain Mutations in BCR-ABL1 Leukemia by Ultra-deep Sequencing of Genomic DNA

enthalten in: ResearchSquare.com | 2024

von Sánchez, R. | Dorado, S. | Ruíz-Heredia, Y. | +44

7

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

enthalten in: Advances in therapy | 2024

von Einsele, H. | Moreau, P. | Bahlis, N. | +23

8

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia : Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mahon, F. | Pfirrmann, M. | Dulucq, S. | +65

9

Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Oliver-Caldés, A. | Español-Rego, M. | Zabaleta, A. | +37

10

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Martin, T. | Moreau, P. | Usmani, S. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[49]